Newsroom - Alvotech - Better Access Better Lives

Skip Navigation

Alvotech

Latest news

05 February 2026

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®

02 February 2026

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

29 January 2026

Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg

Media Contact

Benedikt Stefansson

Director of Investor Relations and Global Communications

Phone +354 422 4500

Connect on Linkedin

Media Gallery

Download center for company logos and images

Alvotech 2022. All rights reserved.